Healthy-Lipids Group, Food Science Department, Faculty of Sciences, Universidad Autónoma de Madrid, Francisco Tomás y Valiente, 7, 28049 Madrid, Spain.
Mar Drugs. 2024 Mar 26;22(4):146. doi: 10.3390/md22040146.
Marine microalgae sp. have a high content of docosahexaenoic acid (DHA), an omega-3 fatty acid that is attracting interest since it prevents certain neurodegenerative diseases. The obtention of a bioactive and purified DHA fatty acid ester using a whole-integrated process in which renewable sources and alternative methodologies are employed is the aim of this study. For this reason, lyophilized biomass was used as an alternative to fish oil, and advanced extraction techniques as well as enzymatic modification were studied. Microalgal oil extraction was optimized via a surface-response method using pressurized liquid extraction (PLE) obtaining high oil yields (29.06 ± 0.12%) with a high concentration of DHA (51.15 ± 0.72%). Then, the enzymatic modification of oil was developed by ethanolysis using immobilized B lipase (Novozym 435) at two reaction temperatures and different enzymatic loads. The best condition (40 °C and 200 mg of lipase) produced the highest yield of fatty acid ethyl ester (FAEE) (100%) after 8 h of a reaction attaining a cost-effective and alternative process. Finally, an enriched and purified fraction containing DHA-FAEE was obtained using open-column chromatography with a remarkably high concentration of 93.2 ± 1.3% DHA. The purified and bioactive molecules obtained in this study can be used as nutraceutical and active pharmaceutical intermediates of marine origin.
海洋微藻 sp. 含有丰富的二十二碳六烯酸 (DHA),这是一种 ω-3 脂肪酸,由于它可以预防某些神经退行性疾病,因此引起了人们的兴趣。本研究旨在使用整体综合工艺获得具有生物活性和纯化的 DHA 脂肪酸酯,该工艺采用可再生资源和替代方法。出于这个原因,冻干生物量被用作鱼油的替代品,并研究了先进的提取技术和酶法修饰。通过使用加压液体萃取 (PLE) 的表面响应方法对微藻油进行了优化,从而获得了高油产量(29.06 ± 0.12%)和高 DHA 浓度(51.15 ± 0.72%)。然后,通过使用固定化 B 脂肪酶(Novozym 435)进行乙醇解,开发了油的酶法修饰。在两种反应温度和不同的酶负荷下进行了反应。最佳条件(40°C 和 200 mg 脂肪酶)在 8 h 的反应后产生了最高产率的脂肪酸乙酯 (FAEE)(100%),达到了具有成本效益和替代工艺的效果。最后,使用开管色谱法获得了富含 DHA-FAEE 的富化和纯化馏分,DHA 的浓度高达 93.2 ± 1.3%。本研究中获得的纯化和生物活性分子可作为海洋来源的营养保健品和活性药物中间体。